DCSTAMP

Chr 8

dendrocyte expressed seven transmembrane protein

Also known as: FIND, TM7SF4, hDC-STAMP

The protein is a seven-pass transmembrane receptor that regulates cellular fusion and differentiation in immune cells, playing essential roles in osteoclast formation and bone resorption, myeloid cell differentiation, and dendritic cell antigen presentation. Mutations cause autosomal recessive osteopetrosis, a severe bone disease characterized by dense but brittle bones due to defective osteoclast function. The gene is highly intolerant to loss-of-function variants (pLI nearly 1.0), indicating that complete loss of protein function is likely incompatible with normal development.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
8
Pubs (1 yr)
38
P/LP submissions
0%
P/LP missense
1.16
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryDCSTAMP
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
38 unique Pathogenic / Likely Pathogenic· 61 VUS of 110 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.16LOEUF
pLI 0.000
Z-score 1.11
OE 0.70 (0.441.16)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.36Z-score
OE missense 0.94 (0.841.04)
234 obs / 249.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.70 (0.441.16)
00.351.4
Missense OE0.94 (0.841.04)
00.61.4
Synonymous OE1.16
01.21.6
LoF obs/exp: 11 / 15.8Missense obs/exp: 234 / 249.9Syn Z: -1.28
DN
0.7131th %ile
GOF
0.73top 25%
LOF
0.2387th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

110 submitted variants in ClinVar

Classification Summary

Pathogenic38
VUS61
Likely Benign7
Benign1
38
Pathogenic
61
VUS
7
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
38
0
38
Likely Pathogenic
0
0
0
0
0
VUS
0
55
6
0
61
Likely Benign
0
7
0
0
7
Benign
0
1
0
0
1
Total063440107

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

DCSTAMP · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →